These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 8411771

  • 1. Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.
    Kunihara M, Ohyama M, Nakano M.
    Jpn J Pharmacol; 1993 Jul; 62(3):223-30. PubMed ID: 8411771
    [Abstract] [Full Text] [Related]

  • 2. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
    Vonvoigtlander PF, Lewis RA.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
    [Abstract] [Full Text] [Related]

  • 3. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.
    Wadenberg ML.
    CNS Drug Rev; 2003 Jul; 9(2):187-98. PubMed ID: 12847558
    [Abstract] [Full Text] [Related]

  • 4. Central monoaminergic mechanisms in mice and analgesic activity of spiradoline mesylate, a selective kappa-opioid receptor agonist.
    Kunihara M, Ohyama M, Nakano M.
    Eur J Pharmacol; 1992 Apr 22; 214(2-3):111-8. PubMed ID: 1325350
    [Abstract] [Full Text] [Related]

  • 5. Pre- and post-synaptic effects of spiradoline and U-50488H, selective kappa opioid receptor agonists, in isolated ileum.
    Nomura Y, Hayashi S.
    Scand J Gastroenterol; 1992 Apr 22; 27(4):295-302. PubMed ID: 1317055
    [Abstract] [Full Text] [Related]

  • 6. Combined effects of psychostimulants and morphine on locomotor activity in mice.
    Mori T, Ito S, Narita M, Suzuki T, Sawaguchi T.
    J Pharmacol Sci; 2004 Dec 22; 96(4):450-8. PubMed ID: 15599100
    [Abstract] [Full Text] [Related]

  • 7. Prolonged antagonism of morphine-induced locomotor stimulation by kappa opioid agonists: enhancement by prior morphine exposure.
    Pearl SM, Glick SD.
    Neurosci Lett; 1996 Jul 26; 213(1):5-8. PubMed ID: 8844699
    [Abstract] [Full Text] [Related]

  • 8. Analgesic activity of spiradoline mesylate (U-62,066E), a kappa opioid agonist in mice.
    Kunihara M, Ohyama M, Nakano M, Hayashi S.
    Life Sci; 1989 Jul 26; 45(13):1191-8. PubMed ID: 2796604
    [Abstract] [Full Text] [Related]

  • 9. Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release.
    Sershen H, Hashim A, Lajtha A.
    Brain Res; 1998 Aug 10; 801(1-2):67-71. PubMed ID: 9729284
    [Abstract] [Full Text] [Related]

  • 10. Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066).
    Piercey MF, Einspahr FJ.
    J Pharmacol Exp Ther; 1989 Oct 10; 251(1):267-71. PubMed ID: 2552077
    [Abstract] [Full Text] [Related]

  • 11. The kappa-opioid receptor agonist spiradoline differentially alters the rotational response to dopamine D1 and D2 agonists.
    Engber TM, Boldry RC, Chase TN.
    Eur J Pharmacol; 1991 Jul 23; 200(1):171-3. PubMed ID: 1663039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A, Sorrentino L.
    Br J Pharmacol; 1997 Mar 23; 120(6):1001-6. PubMed ID: 9134209
    [Abstract] [Full Text] [Related]

  • 14. Kappa agonist-induced reduction in dopamine release: site of action and tolerance.
    Donzanti BA, Althaus JS, Payson MM, Von Voigtlander PF.
    Res Commun Chem Pathol Pharmacol; 1992 Nov 23; 78(2):193-210. PubMed ID: 1282270
    [Abstract] [Full Text] [Related]

  • 15. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T, Ohno M, Ueki S.
    Eur J Pharmacol; 1988 Oct 26; 156(1):173-6. PubMed ID: 2850208
    [Abstract] [Full Text] [Related]

  • 16. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    Vonvoigtlander PF, Lahti RA, Ludens JH.
    J Pharmacol Exp Ther; 1983 Jan 26; 224(1):7-12. PubMed ID: 6129321
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.